7Suppliers
0Customers
2Debt Items
20Related Chains

Source-Backed Evidence Depth

MAIA Biotechnology, Inc. (MAIA) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

10Total relationships
5Distinct source URLs
8High confidence
0.872Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

MAIA Biotechnology, Inc. Suppliers

TickerNameConfidenceEvidence
H-C-WAINWRIGHT-CO-LLC H-C-WAINWRIGHT-CO-LLC 92% the Company's sales agent thereunder
KONIK-CAPITAL-PARTNERS-LLC KONIK-CAPITAL-PARTNERS-LLC 92% the Company agreed to issue and sell in an underwritten public offering (the “Offering”) an aggregate of 20,000,000 shares (the “Shares”) of the Company’s common stock, par value $0.0001 per share (“…
REGN Regeneron Pharmaceuticals, Inc. 92% In February 2021, the Company entered into a Drug Supply Agreement (the “Drug Supply Agreement”) with Regeneron Pharmaceuticals, Inc. (“Regeneron”) to perform one clinical trial for the treatment of …
REGN Regeneron Pharmaceuticals, Inc. 92% Reciprocal relationship from REGN graph: Reciprocal relationship from MAIA graph: Reciprocal relationship from REGN graph: Reciprocal relationship from MAIA graph: Reciprocal relationship from REGN g…
UTSW UTSW 90% Pursuant to the UTSW1 Agreement, the Company paid to UTSW a nominal one-time upfront license fee.
ORANY ORANY 72% ncy. In addition to its own review, the FDA may refer applications for novel drug or biological products or drug or biological products which present difficult questions of safety or efficacy to an a…
ORANY ORANY 72% Reciprocal relationship from ORANY graph: Reciprocal relationship from MAIA graph: Reciprocal relationship from ORANY graph: Reciprocal relationship from MAIA graph: Reciprocal relationship from ORAN…

MAIA Biotechnology, Inc. Customers

No clients on recordNo downstream customers found in our database for MAIA Biotechnology, Inc..

MAIA Biotechnology, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
MAIA-DEBT-10859 Xbrl Convertible 90% xbrl convertible detail from xbrl 2021-12-31.
MAIA-DEBT-10858 Warrants outstanding: 452731 90% xbrl warrant detail from xbrl 2025-12-31.

MAIA Biotechnology, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for MAIA Biotechnology, Inc..

MAIA Biotechnology, Inc. Ownership

HolderNameConfidenceEvidence
MAIA-OWNER-SOLAS-CAPITAL-MANAGEMENT-LLC Solas Capital Management, LLC 90% 13F overlay lists Solas Capital Management, LLC as top holder; 32 tracked holders.

MAIA Biotechnology, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
ORANY ORANGE 100.00 1 ['supplier']
REGN Regeneron Pharmaceuticals, Inc. 100.00 1 ['supplier']
CHKP Check Point Software Technologies Ltd. 50.00 2
CPRX Catalyst Pharmaceuticals, Inc. 50.00 2
AYTU Aytu BioPharma, Inc. 50.00 2
CYCN Cyclerion Therapeutics, Inc. 50.00 2
DARE Daré Bioscience, Inc. 50.00 2
DWTX Dogwood Therapeutics, Inc. 50.00 2
CANF Can-Fite BioPharma Ltd. 50.00 2
DFTX Definium Therapeutics, Inc. 50.00 2
CHUC Charlie's Holdings, Inc. 50.00 2
CLNE Clean Energy Fuels Corp. 50.00 2
FENC Fennec Pharmaceuticals Inc. 50.00 2
EQR Equity Residential 50.00 2
CNOB ConnectOne Bancorp, Inc. 50.00 2
D Dominion Energy, Inc. 50.00 2
EDSA Edesa Biotech, Inc. 50.00 2
ESS Essex Property Trust, Inc. 50.00 2
ED Consolidated Edison, Inc. 50.00 2
AMZE Amaze Holdings, Inc. 50.00 2
🔐
MAIA
Unlock MAIA Supply Chain Data
Verified relationships include:
H-C-WAINWRIGHT-CO-LLCH-C-WAINWRIGHT-CO-LLCSupplier92%
KONIK-CAPITAL-PARTNERS-LLCKONIK-CAPITAL-PARTNERS-LLCSupplier92%
+6 more relationships locked
Subscribe — View plans →